| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| James B. Breitmeyer | Chief Executive Officer, Director | $325K | Feb 14, 2024 | ||
| Hale David F | Director | $283K | Jun 20, 2024 | ||
| Robert James Wills | Director | $89.6K | Jun 20, 2024 | ||
| Richard G. Vincent | Chief Financial Officer | $73.1K | Feb 14, 2024 | ||
| Salim Yazji | Chief Medical Officer | $63.8K | Feb 14, 2024 | ||
| Gunnar F. Kaufmann | Chief Scientific Officer | $47K | Jun 12, 2023 | ||
| Chase C. Leavitt | General Counsel/Secretary | $42K | Feb 14, 2024 | ||
| Rajesh Krishnan | Cto/Cso | $21.8K | Feb 14, 2024 | ||
| Michael G. Carter | Director | Jun 20, 2024 | |||
| Jinzhu Chen PhD | Director | Jun 16, 2022 | |||
| Xin Nakanishi | Director | Jun 28, 2023 | |||
| Jill DeSimone | Director | Jun 20, 2024 | |||
| Daniel L. Kisner | Director | Jun 20, 2024 | |||
| Charles Theuer | Director | Jun 20, 2024 | |||
| Rosemary Mazanet | Director | Jun 20, 2024 | |||
| William R. Larue | Director | Jun 20, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|